4//SEC Filing
Risser Eric Blasius 4
Accession 0001125345-24-000056
CIK 0001125345other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:20 PM ET
Size
10.2 KB
Accession
0001125345-24-000056
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Risser Eric Blasius
V P, Business Development
Transactions
- Exercise/Conversion
Common Stock
2024-03-04$10.15/sh+15,000$152,250→ 80,059 total - Sale
Common Stock
2024-03-04$19.63/sh−26,159$513,501→ 38,900 total - Exercise/Conversion
Employee stock option (right to buy)
2024-03-04−15,000→ 155,000 totalExercise: $10.15Exp: 2032-02-22→ Common Stock (15,000 underlying) - Sale
Common Stock
2024-03-04$20.00/sh−15,000$300,000→ 65,059 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2022.
- [F2]This transaction was executed in multiple trades at prices ranging from $19.50 to $19.78. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
Documents
Issuer
MACROGENICS INC
CIK 0001125345
Entity typeother
Related Parties
1- filerCIK 0001587774
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:20 PM ET
- Size
- 10.2 KB